Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

TOTALIGENT INC. (TGNT)

  • Business News
  • May 28, 2026, 12:05 UTC
  • 1
  • 1 comments

Totaligent Announces Formation of Joint Venture with GloMed Solutions to Commercialize Advanced Biologics in Japan and APAC

Market reaction Comment Full text

VERRICA PHARMACEUTICALS INC. (VRCA)

  • Business News
  • May 28, 2026, 12:05 UTC
  • 1
  • 1 comments

Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

Market reaction Comment Full text

BELISS CORPORATION (BLIS)

  • Business News
  • May 28, 2026, 12:05 UTC
  • 1
  • 1 comments

NAPC Defense Publishes Strategic White Paper Detailing Government Contract Platform, IDIQ Positioning, and Preliminary Financial Projections

Market reaction Comment Full text

Aptevo Therapeutics Inc. (APVO)

  • Business News
  • May 28, 2026, 12:05 UTC
  • 2
  • 1 comments

Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer

Market reaction Comment Full text

TRIDENT DIGITAL TECH HOLDINGS LTD (TDTH)

  • Business News
  • May 28, 2026, 12:05 UTC
  • 2
  • 1 comments

Trident Digital Tech Holdings Ltd. (Nasdaq: TDTH) and U.S Based Digital Innovations Group Execute Binding LOI to Deploy IRMA AI Engine Across Asia-Pacific Markets

Market reaction Comment Full text

INOVIO PHARMACEUTICALS, INC. (INO)

  • Business News
  • May 28, 2026, 12:05 UTC
  • 2
  • 1 comments

INOVIO to Participate in Upcoming Scientific and Investor Conferences

Market reaction Comment Full text

BAKER GLOBAL ASSET MANAGEMENT INC. (BAKR)

  • Business News
  • May 28, 2026, 12:04 UTC
  • 2
  • 1 comments

Baker Global Asset Management, Inc. Signs Non-Binding Letter of Intent with QLUBO Nordic AB for Potential Strategic European Expansion

Market reaction Comment Full text

Alto Neuroscience Inc. (ANRO)

  • Business News
  • May 28, 2026, 12:03 UTC
  • 3
  • 1 comments

Alto Neuroscience, Inc. - Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.D. to Board of Directors

Market reaction Comment Full text

ALARUM TECHNOLOGIES LTD (ALAR)

  • Business News
  • May 28, 2026, 12:03 UTC
  • 2
  • 1 comments

Alarum Technologies Reports 64% Revenue Growth to $11.7 Million in First Quarter 2026, Driven by Strong AI Demand

Market reaction Comment Full text

ALTO NEUROSCIENCE, INC. (ANRO)

  • Business News
  • May 28, 2026, 12:03 UTC
  • 3
  • 1 comments

Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.D. to Board of Directors

Market reaction Comment Full text
  • Previous
  • 1424
  • 1425
  • 1426
  • 1427
  • 1428
  • Next

Search

News categories

  • Technical Exchange News(13353)
  • Event(6229)
  • SEC News(341012)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(189189)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin